Good evaluation of Everolimus for Lung #NeuroendocrineCancer patient options https://t.co/qtPPCYxwib @UKINETS @lungdiagnosis @BartsPathology

Why is #Everolimus still the only drug specifically approved for Lung #NETs ? And even this was based on the results of large-randomised Phase III trials in mixed GI & Lung NETs. We have to do more, and stop including Lung as an afterthought https://t